Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vancomycin + Collatamp G is a combination therapy used primarily for infection prevention and treatment in surgical settings. This combination consists of vancomycin, a glycopeptide antibiotic, and Collatamp G, which is a gentamicin-eluting collagen sponge. ## Description Vancomycin + Collatamp G represents a dual antibiotic approach for preventing and treating surgical site infections. This combination therapy utilizes two different antibiotics with complementary antimicrobial spectra: 1. Vancomycin is a glycopeptide antibiotic effective against gram-positive bacteria, particularly methicillin-resistant Staphylococcus aureus (MRSA). 2. Collatamp G is a gentamicin-eluting collagen sponge that provides local delivery of gentamicin, an aminoglycoside antibiotic effective against many gram-negative bacteria. The collagen sponge component serves multiple purposes - it acts as a delivery vehicle for the antibiotics, provides hemostatic effects to control bleeding, and the collagen itself is bioabsorbable, eliminating the need for removal[1][2]. ## Clinical Applications This combination is primarily used in surgical settings where there is high risk of infection, particularly in: - Cardiac surgery (sternotomy closures) - Vascular surgery (high-risk groin incisions) - Orthopedic procedures - Wound management for complex or infected wounds Studies have shown that this combination can significantly reduce surgical site infection rates compared to standard care. For example, one study found that the superficial sternal wound infection rate was 2.1% in the Collatamp group versus 6.2% in the control group[6]. ## Mechanism of Action The combination works through complementary mechanisms: - Vancomycin inhibits bacterial cell wall synthesis by binding to the D-Ala-D-Ala terminus of peptidoglycan precursors, preventing cross-linking and compromising cell wall integrity in gram-positive bacteria[1][3]. - Gentamicin (from Collatamp G) binds to the 30S ribosomal subunit, inhibiting protein synthesis in susceptible gram-negative bacteria[7]. - The collagen component provides a matrix for controlled release of both antibiotics while also promoting hemostasis and wound healing[1][6]. The local delivery system allows for high concentrations of antibiotics at the surgical site while minimizing systemic exposure and associated toxicity risks[1][2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on vancomycin + gentamicin-collagen sponge.